Related Experiment Video
Updated: May 2, 2026

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
Published on: August 6, 2021
Risk factors associated with retinal vein occlusion
F Martínez1, E Furió, M J Fabiá
1Internal Medicine Department, Fundación de Investigación del Hospital Clínico de Valencia- INCLIVA, Hospital Clínico Universitario, Universidad de Valencia, Valencia, Spain; "Centro de Investigación Biomédica en Red (CIBER) de Fisiopatología, Obesidad y Nutrición (CIBEROB)", Institute of Health Carlos III, Minister of Health, Madrid, Spain.
Hypertension is a primary driver of retinal vein occlusion (RVO), often presenting as the first sign of undiagnosed high blood pressure. Atherosclerotic disease is also common in RVO patients.
Area of Science:
- Ophthalmology
- Vascular Medicine
- Cardiology
Background:
- Retinal vein occlusion (RVO) is a significant retinal vascular disease.
- Arterial risk factors play a more critical role in RVO development than venous factors.
Purpose of the Study:
- To investigate the specific risk factors contributing to the initial occurrence of RVO.
- To assess the prevalence of arterial and venous risk factors in RVO patients.
Main Methods:
- A cohort of 100 RVO patients underwent clinical assessments, including blood pressure, BMI, and laboratory tests (homocysteine, antiphospholipid antibodies).
- Carotid ultrasonography was performed on half the patients.
- Control groups from population-based studies and venous thromboembolic disease patients were used for comparison.
Main Results:
- RVO patients exhibited significantly higher blood pressure and hypertension prevalence compared to the general population.
- A substantial portion of RVO patients had undiagnosed hypertension and evidence of subclinical organ damage.
- Homocysteine levels and antiphospholipid antibody prevalence in RVO patients were comparable to those with venous thromboembolic disease.
Conclusions:
- Hypertension is identified as the principal factor in RVO development, with RVO potentially being the initial clinical manifestation.
- Most RVO patients showed signs of underlying atherosclerotic disease.
- Thrombophilia studies were not deemed useful for RVO, while hyperhomocysteinemia and antiphospholipid antibodies were more prevalent than in the general population.
Related Concept Videos
Diabetic Retinopathy
Varicose Veins I: Introduction
Photoreceptors and Visual Pathways
Venous Thrombosis I: Introduction
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

